EFFIGENE PHARMACEUTICALS, INC.

Basic Information

EFFIGENE PHARMACEUTICALS, INC.
c/o Emtech Bio
ATLANTA, GA, 30306

Company Profile

n/a

Additional Details

Field Value
DUNS: 808050327
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Developing Small Molecules to Potentiate RNA Interference

    Amount: $115,422.00

    DESCRIPTION (provided by applicant): SiRNAs are synthetic double-stranded oligonucleotides of ~21 base pairs. When applied to cells, siRNAs can effectively and specifically silence their target genes, ...

    STTR Phase I 2009 Department of Health and Human Services
  2. Developing Adjuvant SiRNA Therapy for Huntington's Disease

    Amount: $99,960.00

    DESCRIPTION (provided by applicant): SiRNAs are synthetic double-stranded oligonucleotides of ~21 base pairs. When applied to cells, siRNAs can effectively and specifically silence their target genes, ...

    STTR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government